Search results for: 'virtual diagnostics'

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...

This research service analyses the market opportunities for in-vitro diagnostics in major sub-Saharan African countries like Botswana, Kenya, Mozambique, Namibia, South Africa, Uganda, Tanzania, Zambia and Zimbabwe. It also provides an overview of the market in these regions and details the market drivers, restraints and industry challenges. Togeth...

The biosensor industry has been making rapid strides for the past few years. Biosensors are increasingly being used for a large number of diverse applications ranging from home diagnostics to security and biodefence. Large investments continue to be made into biosensor research. Single platform with multipurpose testing applications are being devel...

The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Leading players in the global life sciences LIMS market, including LabWare, Benchling, Clinisys, LabVan...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, and diagnostics industry. The issue includes advanced medical devices such as therapeutic device for heart failure, automated robotic disinfection system, remote monitoring of gravity IV ...

The U.S. Pharmacogenomics Market report focuses on the varying dynamics of the pharmacogenomics market. This report covers the Pharmacogenomics services, Gene-based Diagnostics, and Orphan Drugs segments. This report provides an in-depth analysis of the revenue sales forecasts for the market, drivers and restraints that affect the current and futu...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

This healthcare market outlook is from the time period 2009 to 2012 and covers the Asia Pacific region as a whole and also South Korea specifically. It goes over the pharmaceuticals, medical devices, clinical diagnostics, medical imaging, life sciences and healthcare IT market segments. Within the coverage of these segments, the presentation also o...

This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...